Wells Fargo assumed coverage of Globus Medical (GMED) with an Overweight rating and $104 price target The firm is maintaining the current rating, price target and estimates.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED:
- Globus Medical price target raised to $104 from $98 at Wells Fargo
- Globus Medical Earnings Call Shows Profitable Growth
- Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation
- Globus Medical price target raised to $115 from $105 at Truist
- Globus Medical price target raised to $115 from $112 at Canaccord